Additional analyses Sample Clauses

The 'Additional analyses' clause defines the conditions under which further examinations or evaluations beyond the original scope may be conducted. This clause typically outlines who can request such analyses, the process for approval, and any associated costs or responsibilities. For example, it may allow a party to request extra laboratory tests or data reviews if initial results are inconclusive. Its core function is to provide a structured mechanism for addressing uncertainties or new questions that arise, ensuring flexibility and thoroughness in the agreement's execution.
Additional analyses. The collective motive versus the individual motive. In both the high respect condition and the average respect condition, participants showed enhanced levels of affective commitment when compared with participants in the low respect condition (see Table 5). To confirm our predictions that when people are respected, enhanced feelings of affective commitment will be related to more engagement in discretionary group efforts, we subjected affective commitment, situational group attachment an>iety, and discretionary group efforts to linear regression analyses. Linear regression analysis within the relevant conditions (i.e. the high respect condition and average respect condition) showed the following: After having received higher or average respect, when both affective commitment and situational group attachment an>iety were in the equation, only affective commitment, R2ch = .06, β = .25, t(2,90) = 2.48, p < .05, revealed a significant relation with the discretionary group efforts measure, whereas situational group attachment an>iety showed no significant relation to the discretionary group efforts measure, R2ch = .02, β = .12, t(2,90) = 1.22, p = .23 (see Figure 1). Figure 1 Results of linear regression analysis of Discretionary Group Efforts on Affective Commitment and Situational Group Attachment Anxiety when Respected or Disrespected Discretionary group efforts Affective commitment β = .25* When respected (the collective motive) Situational group attachment anxiety β = .12ns When disrespected (the individual motive) β = .02ns Discretionary group efforts Affective commitment Situational group attachment anxiety β = .31* Note. * = significant at p < .05 ns = not significant By contrast, participants in the low respect condition indicated to have more feelings of situational group attachment an>iety compared to participants in respectively the high respect condition or average respect condition (see Table 5). To further support our assumption that when people perceive themselves as disrespected, displays of discretionary group efforts will appear due to higher levels of situational group attachment an>iety for those in the disrespected condition, we subjected affective commitment, situational group attachment an>iety, and discretionary group efforts to linear regression analyses. Within the disrespect condition when both affective commitment and situational group attachment an>iety were in the equation, instead of affective commitment, R2ch = .01, β = .02, t(2...
Additional analyses. Both perceptions of the self in relation to the group (perceived inclusion and perceived intra-group status) showed a moderate, positive relation with cognitive accessibility of fairness (intercorrelations are depicted in Table 3). Nevertheless, evidence that either inclusion or intra-group status mediated the effect of intra-group respect on the cognitive accessibility of fairness could not be demonstrated.
Additional analyses. To ensure that our results are not sensitive to alternative specifications, we now examine various board-independence classifications and alternative regression specifications. All untabulated analyses are available upon request.
Additional analyses. The total amount specified in paragraph 3.01 does not include the cost of any additional analyses requested by the City, such as analysis of bottom samples. The Council will carry out any such additional analyses at the request of the City and subject to the availability of Council resources for carrying out such analyses. The Council will bill the City after the end of the Monitoring Period for any such additional analyses at the Council’s actual cost, and the City will promptly reimburse the Council for any such costs billed. The costs for additional analyses are provided in Exhibit A.
Additional analyses. Another way to examine congruency with network data is the overlap between the three interdependency networks. Therefore, a next step we undertook was establishing the effect of overlapping patterns of the three interdependence relationships on performance. This approach differs from the congruency measure we used earlier in that here we can take into account the actual overlap of interdependency relationships between the team members. The density measure we used, describes the overall level of the three interdependency relationships reported by network members. That measure did not take into account if ties between team members are consistent in each interdependency network. The overlap of the interdependency networks measures if team members ▇▇▇▇ and ▇▇▇▇ are mutually task interdependent, and/or dependent upon each other for task-related information, and/or consider each other as friends. This overlap was calculated using the QAP correlation procedure in UCINET 5 (▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇, 1999). With this procedure, the correlation between two different matrices is calculated, using all elements in the matrices. The QAP procedure compares the observed correlation with a distribution of random correlations generated according to the null hypothesis of no relationship between the matrices. This procedure works by permuting the rows and columns (together) of one of the input matrices, and then correlating the permuted matrix with the other data matrix. This process is repeated hundreds of times to build up a distribution of correlations under the null hypothesis. The p-value is given by the proportion of random correlations that are as large as or larger than the observed correlation. Using this procedure we can only assess the overlap between patterns of two interdependence relationships at a time. The three correlation coefficients for each team were then regressed on team performance. The results are shown in table 4.3. We find a marginally significantly negative effect with respect to the overlap between functional and affect-based interdependence. The results reveal that the more the pattern of functional interdependence relationships shows an overlap with the pattern of affect-based interdependence relationships (regardless of the overall level of this type of interdependence in that team), the more negative the team performance. The overlap between functional and cognitive interdependence and between cognitive and affect-based interdependence sho...
Additional analyses. CADI shall consider whether the results/findings under any of the above-described monitoring warrant further review or analysis, or potentially indicate a systemic issue(s).
Additional analyses. For patients with a hematological malignancy or aplastic anemia, the incidence rate ratio of bacteremia the day after transfusion of at least one old platelet concentrate was 0.54 (CI 0.31 to 0.87) compared to transfusion of only fresh platelet concentrates. After receiving a single old, compared to a single fresh, platelet concentrate the incidence rate ratio was 0.44 (95% CI 0.26 to 0.76). If a patient received one old platelet concentrate in the preceding three, five, or seven days, the estimates were similar, although not statistically significant (figure 3, panel B and supplemental material).
Additional analyses. To shed more light onto the immediate effects of ASU 2022-04 disclosures about supplier financing agreements on financial analysts, we examine the changes in analysts’ cash flow forecast properties following a supplier financing disclosure. We focus on firms that eventually make a supplier financing disclosure in our sample period and investigate changes in cash flow forecast properties before and after the disclosure. We identify cash flow forecast properties immediately after the earnings announcement associated with the 10-Q filing. This first-difference approach allows us to uncover temporal effects of disclosures in treatment firms. Moreover, not all treatment firms provide supplier finance disclosure during the first quarter of 2023. For some firms the initial disclosure of supplier financing agreements is in the second 10-Q filing after the effective date of ASU 2022-04. This staggered setting, along with firm and quarter fixed effects allows us perform a difference-in-difference analysis. Note that we use quarterly Compustat data to calculate accounting variables for this analysis. Table 6, Panel A presents the results for this analysis with the sample restricted to supplier financing firms in the quarters before and after the disclosure. In columns 1 and 2, we find that supplier financing firms experience a decline in analysts’ cash flow forecast coverage. Column 3 shows that analysts revise their cash flow forecasts downwards after the disclosure of supplier financing agreements. In column 4, cash flow forecast dispersion increases after the disclosure of supplier financing agreements. Column 5 shows no difference in the accuracy of cash flow forecasts. The decrease in cash flow coverage and increase in dispersion can be interpreted as analysts not receiving a precise cash flow signal from the supplier financing disclosure. The downward forecast revision after earnings announcements for supplier financing firms is perhaps due to an increased skepticism about reported cash flows given the existing supplier financing agreements. However, given no change in cash flow forecast accuracy, we fail to find any evidence that the ASU 2022-04 disclosures improves the analysts’ ability to forecast cash flows. Overall, these results provide initial evidence that ASU 2022-04 disclosures do not assist financial analysts with their cash flow forecasts. To complement the results in Panel A, we extend our sample by adding control firms using propensity score match...

Related to Additional analyses

  • Special Analyses It is hereby certified that these regulations will not have a significant economic impact on a substantial number of small entities. This certification is based on the fact that it is unlikely that a substantial number of small entities will hold REMIC residual interests. Therefore, a Regulatory Flexibility Analysis under the Regulatory Flexibility Act (5 U.S.C. chapter 6) is not required. It has been determined that this Treasury decision is not a significant regulatory action as defined in Executive Order 12866. Therefore, a regulatory assessment is not required. It also has been determined that sections 553(b) and 553(d) of the Administrative Procedure Act (5 U.S.C. chapter 5) do not apply to these regulations. The principal author of these regulations is ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇. However, other personnel from the IRS and Treasury Department participated in their development. 26 CFR Part 1 Income taxes, Reporting and record keeping requirements.

  • Development Reports Beginning six months after Effective Date and ending on the date of first commercial sale of a Licensed Product in the United States, LICENSEE shall report to Cornell progress covering LICENSEE's (and Affiliate's and Sublicensee's) activities and efforts in the development of rights granted to LICENSEE under this Agreement for the preceding six months. The report shall include, but not be limited to, activities and efforts to develop and test all Licensed Products and obtain governmental approvals necessary for marketing the same. Such semi-annual reports shall be due within sixty days (60) of the reporting period and shall use the form as provided herein as Appendix C.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Project Planning GOVERNMENTAL APPROVALS; ENVIRONMENTAL COMPLIANCE; PUBLIC INFORMATION 30 4.1 Planning and Engineering Activities 30 4.2 Site Conditions 30 4.3 Governmental Approvals 30 4.4 Environmental Compliance 34 4.5 Community Outreach and Public Information 35

  • Quantitative Analysis Quantitative analysts develop and apply financial models designed to enable equity portfolio managers and fundamental analysts to screen potential and current investments, assess relative risk and enhance performance relative to benchmarks and peers. To the extent that such services are to be provided with respect to any Account which is a registered investment company, Categories 3, 4 and 5 above shall be treated as “investment advisory services” for purposes of Section 5(b) of the Agreement.”